Tuberculosis in special populations

被引:9
|
作者
Santin Cerezales, Miguel [1 ]
Navas Elorza, Enrique [2 ]
机构
[1] Univ Barcelona, Inst Salud Carlos III, IDIBELL,Dept Ciencias Clin, Hosp Univ Bellvitge,Serv Enfermedades Infecciosas, Barcelona, Spain
[2] Hosp Univ Ramon y Cajal, Serv Enfermedades Infecciosas, Madrid, Spain
来源
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA | 2011年 / 29卷
关键词
Tuberculosis; Immunosupression; Comorbidity; Immigration; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PERSONS; FOREIGN-BORN PERSONS; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; RISK-FACTORS; TRANSMISSION;
D O I
10.1016/S0213-005X(11)70014-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibility to infection, the pathogenesis and the clinical manifestations of tuberculosis (TB) depend on the immunological status of the host. Immunological status is largely determined by age and comorbidities, but is also affected by other less well known factors. In Spain, most incidental cases of TB arise from the reactivation of remotely acquired latent infections and are favored by the aging of the population and the use of aggressive immunosuppressive therapies. The diagnosis and management of TB in these circumstances is often challenging. On the one hand, the atypical presentation with extrapulmonary involvement may delay diagnosis, and on the other, the toxicity and interactions of the antituberculous drugs frequently make treatment difficult. Immigration from resource-poor, high incidence TB countries, where the social and economic conditions are often suboptimal, adds a new challenge to the control of the disease in Spain. This chapter summarizes our current knowledge of epidemiological, clinical and treatment aspects of TB in particularly susceptible populations. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [31] Trials in special populations
    Walson, PD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1996, 57 (03): : 231 - 231
  • [32] Equivalence in special populations
    Ogata, H
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2000, 25 (01) : 72 - 72
  • [33] Trials in special populations
    Walson, PD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1997, 58 (09): : 631 - 632
  • [34] Trials in special populations
    Connor, JD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (01): : 45 - 45
  • [35] Trials in special populations
    Connor, JD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (07): : 520 - 520
  • [36] COUNSELING SPECIAL POPULATIONS
    LARSON, PC
    PROFESSIONAL PSYCHOLOGY, 1982, 13 (06): : 843 - 858
  • [37] Bioanalysis in special populations
    Blair, Ian
    Lachance, Sylvain
    Tang, Daniel
    Zhong, Dafang
    BIOANALYSIS, 2014, 6 (23) : 3077 - 3080
  • [38] Mentoring Special Populations
    Whitfield, Keith E.
    Edwards, Christopher L.
    EDUCATIONAL GERONTOLOGY, 2011, 37 (05) : 422 - 439
  • [39] Trials in special populations
    Connor, JD
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1998, 59 (12): : 847 - 849